These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 17533124

  • 21. Synthesis and in vitro cytotoxicity of novel lipophilic (diamine)platinum(II) complexes of salicylate derivatives.
    Ye QS, Lou LG, Liu WP, Yu Y, Chen XZ, Hou SQ, Gao WQ, Liu Y.
    Bioorg Med Chem Lett; 2007 Apr 15; 17(8):2146-9. PubMed ID: 17306532
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
    Rakić GM, Grgurić-Sipka S, Kaluderović GN, Gómez-Ruiz S, Bjelogrlić SK, Radulović SS, Tesić ZLj.
    Eur J Med Chem; 2009 May 15; 44(5):1921-5. PubMed ID: 19070943
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK, Kim G, Gam J, Cho YB, Kim HT, Tai JH, Kim KH, Hong WS, Park JG.
    J Med Chem; 1994 May 13; 37(10):1471-85. PubMed ID: 8182706
    [Abstract] [Full Text] [Related]

  • 26. Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
    New EJ, Roche C, Madawala R, Zhang JZ, Hambley TW.
    J Inorg Biochem; 2009 Aug 13; 103(8):1120-5. PubMed ID: 19564043
    [Abstract] [Full Text] [Related]

  • 27. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P, Kalayda GV, Jaehde U, Dulk Hd, Brouwer J, Reedijk J.
    J Inorg Biochem; 2009 May 13; 103(5):791-6. PubMed ID: 19303143
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. New mononuclear and homodinuclear Pt(ii) complexes with heterocyclic nitrogen chelates: synthesis, characterization, intercalating ability and in vitro cytotoxic activity evaluation.
    De Pascali SA, Migoni D, Papadia P, Romano A, Marsigliante S, Pellissier A, Chardon-Noblat S, Ciccarese A, Fanizzi FP.
    Dalton Trans; 2008 Nov 21; (43):5911-21. PubMed ID: 19082047
    [Abstract] [Full Text] [Related]

  • 30. Synthesis, cytotoxicity and DNA binding levels of tri-functional mononuclear platinum(II) complexes.
    Zhang J, Gong Y, Zheng X, Yang M, Cui J.
    Eur J Med Chem; 2008 Feb 21; 43(2):441-7. PubMed ID: 17587465
    [Abstract] [Full Text] [Related]

  • 31. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes.
    Mellor HR, Snelling S, Hall MD, Modok S, Jaffar M, Hambley TW, Callaghan R.
    Biochem Pharmacol; 2005 Oct 15; 70(8):1137-46. PubMed ID: 16139250
    [Abstract] [Full Text] [Related]

  • 32. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S, Jakupec MA, Kukushkin NV, Groessl M, Hartinger CG, Semenova O, Zorbas H, Kukushkin VY, Keppler BK.
    Mol Pharmacol; 2007 Jan 15; 71(1):357-65. PubMed ID: 17050805
    [Abstract] [Full Text] [Related]

  • 33. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.
    Wheate NJ, Taleb RI, Krause-Heuer AM, Cook RL, Wang S, Higgins VJ, Aldrich-Wright JR.
    Dalton Trans; 2007 Nov 21; (43):5055-64. PubMed ID: 17992290
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
    Zhang J, Li Y, Sun J.
    Eur J Med Chem; 2009 Jun 21; 44(6):2758-62. PubMed ID: 19056150
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates.
    Zhang J, Zhao X.
    Eur J Med Chem; 2007 Feb 21; 42(2):286-91. PubMed ID: 17084487
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antitumor dinuclear platinum(II) complexes derived from a novel chiral ligand.
    Gao C, Xu G, Gou S.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6386-8. PubMed ID: 21920736
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
    Miernicka M, Szulawska A, Czyz M, Lorenz IP, Mayer P, Karwowski B, Budzisz E.
    J Inorg Biochem; 2008 Feb 01; 102(2):157-65. PubMed ID: 17868889
    [Abstract] [Full Text] [Related]

  • 40. Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity.
    Xue Z, Lin M, Zhu J, Zhang J, Li Y, Guo Z.
    Chem Commun (Camb); 2010 Feb 28; 46(8):1212-4. PubMed ID: 20449253
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.